| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,491 |
3,892 |
$344K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,570 |
4,908 |
$272K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,377 |
1,102 |
$104K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,167 |
1,010 |
$97K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
649 |
559 |
$92K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,191 |
1,073 |
$89K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
781 |
641 |
$54K |
| 96127 |
|
1,544 |
1,371 |
$28K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,089 |
1,017 |
$26K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
646 |
515 |
$23K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,003 |
861 |
$16K |
| 92551 |
|
923 |
794 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
845 |
745 |
$13K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
305 |
275 |
$13K |
| 96160 |
|
803 |
679 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
452 |
261 |
$9K |
| 90686 |
|
833 |
728 |
$8K |
| D1206 |
Topical application of fluoride varnish |
289 |
267 |
$7K |
| 90651 |
|
339 |
265 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
82 |
49 |
$4K |
| 90698 |
|
293 |
248 |
$3K |
| 99173 |
|
434 |
387 |
$3K |
| 90674 |
|
153 |
139 |
$3K |
| 90619 |
|
151 |
111 |
$2K |
| 90670 |
|
216 |
194 |
$2K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
159 |
128 |
$2K |
| 99215 |
Prolong outpt/office vis |
22 |
13 |
$2K |
| 83655 |
|
179 |
154 |
$2K |
| 85018 |
|
869 |
739 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
42 |
36 |
$2K |
| 90734 |
|
64 |
53 |
$2K |
| 36416 |
|
311 |
277 |
$1K |
| 90715 |
|
85 |
62 |
$1K |
| 90633 |
|
69 |
65 |
$783.12 |
| 99174 |
|
84 |
74 |
$625.80 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
47 |
46 |
$592.48 |
| 90661 |
|
30 |
30 |
$501.30 |
| 83718 |
|
66 |
54 |
$500.68 |
| 90671 |
|
20 |
15 |
$487.10 |
| 90700 |
|
32 |
28 |
$401.92 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12 |
12 |
$307.80 |
| 82465 |
|
66 |
54 |
$279.84 |
| 90713 |
|
14 |
12 |
$175.84 |
| 90680 |
|
24 |
24 |
$153.60 |
| 90696 |
|
20 |
12 |
$128.00 |
| 90744 |
|
15 |
14 |
$96.00 |
| 81002 |
|
13 |
12 |
$33.80 |